Summary on Nifedipine and Captopril in Treating Hypertension
DOI:
https://doi.org/10.61173/yvbtqx87Keywords:
-Hypertension, Nifedipine, Captopril, Phar-macology, Chemical SynthesisAbstract
Hypertension, a chronic disease, is one of the major health problems worldwide and needs to be controlled through education, early diagnosis and effective management. Two of the most prescribed medications for treating hypertension are nifedipine and captopril. The first chapter gives some background information on hypertension then, the mechanism and target of two drugs are explained. Both of them effectively lower the blood pressure of patients after. Nifedipine achieves this by blocking L-type calcium channels, while captopril produces the same effect by inhibiting the catalysis process of ATI to ATII of ACE. Next, the article moves on to review existing literature on cross-over comparison between nifedipine and captopril and concludes some common trends revealed by previous studies. It was found that nifedipine and captopril have approximately the same level of effectiveness but captopril tends to give less adverse reactions. In addition, synthesize methods of two drugs are also mentioned and compared.
References
[1] Bossert F, Vater W (1964) DOS, German patent No. 1493677
[2] Vater W, Kroneberg G, Hoffmeister F, Saller H, Meng K, Oberdorf A, Puls W, Schlossmann K, Stoepel K. (1972) Pharmacology of 4-(2’-nitrophenyl)-2,6-dimethyl-1,4- dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)
[3] Ondetti MA, Williams NJ, Sabo EF, Pluscec J, Weaver ER, Kocy O. (1971) Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca: Isolation, elucidation of structure, and synthesis. Biochemistry 1971; 10: 4033-4039
[4] T.P. Snutch. (2009) Encyclopedia of Neuroscience: L-Type Calcium Channel
[5] M Takahashi, M J Seagar, J F Jones, B F Reber, W A Catterall. (1987) Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle.
[6] Marina Angelini, Nicoletta Savalli, Federica Steccanella, Riccardo Olcese. (2022) Nifedipine binding to human Cav1.1 allosterically sets 3 out of 4 voltage sensors into their “relaxed state”.
[7] Tipnis S.R., Hooper N.M., Hyde R. (2000) A human homologue of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275(43):33238–33243.
[8] Kenneth E Bernstein, Xiao Z Shen, Romer A Gonzalez- Villalobos, Sandrine Billet, Derick Okwan-Duodu, Frank S Ong, Sebastien Fuchs. (2011) Different in vivo functions of the two catalytic domains of angiotensin converting enzyme (ACE).
[9] W W Klein, W Stuhlinger, G Mahr. (1986) Cross-over comparison between captopril and nifedipine.
[10] Guerrera G, Melina D, Capaldi L, Mauro R, Colivicchi F, Cardillo C, et al. (1990) Sublingually administered captopril versus nifedipine in hypertension emergencies.
[11] Paolo Angeli, MD; Maurizio Chiesa, MD; Lorenza Caregaro, MD; et al. (1991) Comparison of Sublingual Captopril and Nifedipine in Immediate Treatment of Hypertensive Emergencies.
[12] Dadkar VN, Karnik ND, Izar M, Sharma SR, Gandhi YP, Narawane NM, et al. (1993) Sublingual nifedipine and captopril in hypertensive urgencies and emergencies. Indian Heart J. 1993;45(3):185–7.
[13] Ali Maleki, Masumeh sadeghi, Mahyar Zaman, Mohammad Javad Tarrahi, and Behjat Nabatchi. (2011) Nifedipine, Captopril or Sublingual Nitroglycerin, Which can Reduce Blood Pressure the Most? Dean&Francis Yiwei Yin
[14] Jingyu, Jia Pengfei, Liu Sijie, Wang Xiaoxia, Shi Weikang, Gao Xiang, Tian Jichao, An Wenmo and Yang Kai. (2013) Microwave synthesis studies of nifedipine.
[15] Doo H. Nam, Choon S. Lee, Dewey D.Y. Ryu. (December 1984) An Improved Synthesis of Captopril.
[16] Pu Hemei, Yang Zhiling, Yin Xuezhi and Su Shufang. (2011) Summary of Synthesis Route of Captopril.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
